TORO: Ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

Jacques Reynes, Keikawus Arastéh, Bonaventura Clotet, Calvin Cohen, David A. Cooper, Jean François Delfraissy, Joseph J. Eron, Keith Henry, Christine Katlama, Daniel R. Kuritzkes, Jacob P. Lalezari, Joep Lange, Adriano Lazzarin, Julio S.G. Montaner, Mark Nelson, Mary O'Hearn, Hans Jürgen Stellbrink, Benoit Trottier, Sharon L. Walmsley, Neil E. BussRalph DeMasi, Jain Chung, Lucille Donatacci, Denise Guimaraes, Lucy Rowell, Adeline Valentine, Martin Wilkinson, Miklos P. Salgo

Research output: Contribution to journalArticle

40 Scopus citations

Fingerprint Dive into the research topics of 'TORO: Ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals'. Together they form a unique fingerprint.

Medicine & Life Sciences